MEDICARE REVAMPING REIMBURSEMENT COMMITTEE TO CREATE MORE OPEN PROCESS; COVERAGE FOR NEW TECHNOLOGIES EMERGING AS KEY ISSUE FOR UPCOMING SESSION
This article was originally published in The Gray Sheet
Executive Summary
Medicare carriers will be temporarily excluded from the Health Care Financing Administration's Technology Advisory Committee (TAC) while the agency develops a plan to reconstitute the panel to conform with the Federal Advisory Committee Act.
You may also be interested in...
First HCFA Coverage Panel To Review Stem Cell Transplantation
High dose chemotherapy and stem cell transplantation combination treatment for multiple myeloma will be reviewed Sept. 15-16 by the Health Care Financing Administration Medicare Coverage Advisory Committee's drugs, biologics and therapeutics panel, an Aug. 13 Federal Register notice states.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.